Lopinavir/ritonavir plus nevirapine as a nucleoside-sparing approach in antiretroviral-experienced patients (NEKA study).
Negredo E, Moltó J, Burger D, Côté H, Miró O, Ribalta J, Martínez E, Puig J, Ruiz L, Salazar J, López S, Montaner J, Rey-Joly C, Clotet B.
Negredo E, et al. Among authors: cote h.
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):47-52. doi: 10.1097/00126334-200501010-00009.
J Acquir Immune Defic Syndr. 2005.
PMID: 15608524
Clinical Trial.